<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1980 and 1993, out of 635 patients presenting with an <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagogastric junction, 74 (11.7%) had a <z:hpo ids='HP_0002664'>neoplasm</z:hpo> arising from a columnar specialized epithelium lining the distal esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty of these patients (68%) underwent a curative (R0) resection </plain></SENT>
<SENT sid="2" pm="."><plain>36 patients (72%) were in stage 0, I or II, and the 5-year actuarial survival rate was 44% </plain></SENT>
<SENT sid="3" pm="."><plain>The survival rate dropped to 13% when nodal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> were present </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that the long-lasting symptoms during the pre-neoplastic phase, and a closer endoscopic surveillance allow a early diagnosis of Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Surgical therapy must be radical in these patients in order to improve prognosis </plain></SENT>
</text></document>